Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85
Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...
Piper Sandler Companies Announces Share Repurchase Authorization
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of the company's outstanding common ...
Piper Sandler announces share repurchase authorization for up to $150M
Piper Sandler (PIPR) announced that its board of directors has authorized the repurchase of up to $150 million of the company’s outstanding ...
Piper Sandler raises Amazon stock price target to $265
Piper Sandler adjusted its financial outlook for Amazon.com (NASDAQ:AMZN), increasing the price target to $265 from the previous $225, while maintaining an Overweight rating on the company's shares.
Piper Sandler Reaffirms “Neutral” Rating for Quest Diagnostics (NYSE:DGX)
Piper Sandler restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a research report ...
Kemper price target raised to $86 from $83 at Piper Sandler
Piper Sandler raised the firm’s price target on Kemper (KMPR) to $86 from $83 and keeps an Overweight rating on the shares following quarterly ...
The Cigna Group’s (CI) “Overweight” Rating Reiterated at Piper Sandler
Piper Sandler restated their overweight rating on shares of The Cigna Group (NYSE:CI – Free Report) in a research note published on Monday morning,Benzinga reports. Piper Sandler currently has a $348.
Supernus: New Approval Holds Promise Of Increased Growth
Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...